IVD Information for manufacturers on the inspection of manufacturing sites: Prequalification of male circumcision devices (PQDx_014 V4, Version MC_0, 15 November 2012) PDF Guideline/guidance
IS Information Note - Mylan Laboratories Ltd (Viatris, Inc.) Indore, Pithampur, India (31 March 2025) PDF Information note
M Information on the GMP status of Micro Labs Kumbalgodu (ML08) manufacturing facility PDF Information note
IVD Instructions and requirements for Emergency Use Listing (EUL) submission: In vitro diagnostics detecting antibodies to SARS-CoV-2 virus PDF Guideline/guidance
IVD Instructions and requirements for Emergency Use Listing (EUL) submission: In vitro diagnostics detecting SARS-CoV-2nucleic acidandrapid diagnostics tests detecting SARS-CoV-2 antigens PDF Guideline/guidance
IVD Instructions for compilation of a product dossier (PQMC_018 v1, 23 January 2012) PDF Guideline/guidance
IVD Instructions for submission requirements: in vitro diagnostics (IVDs) detecting antibodies to Zika virus (PQDx_239 v4, 28 October 2016) PDF Guideline/guidance
IVD Instructions for submission requirements: in vitro diagnostics (IVDs) detecting Zika virus nucleic acid or antigen (DxPQ_240 version 3, 24 October 2016) PDF Guideline/guidance
IVD Instructions for the completion of the pre-submission form for application for prequalification of an in vitro diagnostic PDF Guideline/guidance
IVD Invitation to manufacturers of in vitro diagnostics for SARS-CoV-2 to submit an application for emergency use listing by WHO PDF Guideline/guidance
IVD Invitation to manufacturers of IVDs for mpxv NAT to submit an application for EUL PDF Information note
M Joint UNICEF & WHO meeting with manufacturers and suppliers, Denmark, 24‒26 September 2012: Programme description
M Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 14–27 September 2018: Agenda PDF Information note
ID IVD IS M V VCP Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 18–21 September 2017: Agenda PDF Information note
ID IVD IS M V VCP Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 18–21 September 2017: Agenda PDF Information note
ID IVD IS M V VCP Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 18–21 September 2017: Agenda PDF Information note
ID IVD IS M V VCP Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 18–21 September 2017: Agenda PDF Information note
ID IVD IS M V VCP Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 18–21 September 2017: Agenda PDF Information note
ID IVD IS M V VCP Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 18–21 September 2017: Agenda PDF Information note
M Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 18–21 September 2017: Programme description PDF Information note
ID IVD M V VCP Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 2–5 December 2019: Agenda PDF Information note
ID IVD M V VCP Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 2–5 December 2019: Agenda PDF Information note
ID IVD M V VCP Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 2–5 December 2019: Agenda PDF Information note
ID IVD M V VCP Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 2–5 December 2019: Agenda PDF Information note
ID IVD M V VCP Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 2–5 December 2019: Agenda PDF Information note
M Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers 24–27 September 2018: Programme description PDF Information note
M Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers, Denmark, 18‒21 September 2017: Background for WHO vector control prequalification PDF Information note
M Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers, Denmark, 18‒21 September 2017: Funding for WHO/UNFPA prequalification of condoms and intrauterine devices PDF Presentation
M Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers, Denmark, 18‒21 September 2017: WHO vaccines prequalification overview: vaccines assessment PDF Presentation